Education
About Us
Working with TipRanks
Follow Us
Acarix AB (SE:ACARIX)
:ACARIX
ACARIX Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.17 - kr0.60
Previous CloseN/A
Volume265.37K
Average Volume (3M)1.24M
Market Cap
kr255.83M
Enterprise Valuekr73.18M
Total Cash (Recent Filing)kr53.99M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.93
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,063,743,800
10 Day Avg. Volume804,281
30 Day Avg. Volume1,243,387
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio-1.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acarix AB News
ACARIX FAQ
What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was kr0.17 and its highest was kr0.60 in the past 12 months.
What is Acarix AB’s market cap?
Acarix AB’s market cap is kr255.83M.
When is Acarix AB’s upcoming earnings report date?
Acarix AB’s upcoming earnings report date is Aug 21, 2025 which is in 68 days.
How were Acarix AB’s earnings last quarter?
Acarix AB released its earnings results on May 12, 2025. The company reported -kr0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.013.
Is Acarix AB overvalued?
According to Wall Street analysts Acarix AB’s price is currently Overvalued.
Does Acarix AB pay dividends?
Acarix AB does not currently pay dividends.
What is Acarix AB’s EPS estimate?
Acarix AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acarix AB have?
Acarix AB has 1,063,743,800 shares outstanding.
What happened to Acarix AB’s price movement after its last earnings report?
Acarix AB reported an EPS of -kr0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.019%.
Which hedge fund is a major shareholder of Acarix AB?
Currently, no hedge funds are holding shares in SE:ACARIX
Company Description
Acarix AB
Acarix AB (ACARIX) is a medical technology company specializing in diagnostic solutions for coronary artery disease. The company is focused on non-invasive, innovative products that aid in the early detection and management of heart disease. Acarix is particularly known for its CADScor System, which provides a quick and reliable way to rule out significant coronary artery disease in patients with chest pain symptoms.
Technical Analysis
Integrum AB Class B
―
Q-linea AB
―
SciBase Holding AB
―
SpectraCure AB
―
BrainCool AB
―